Government Context
Documents
Following
Sign in
Documents
Documents by topic
Documents by agency
Following
Sign in
Details
Dockets
›
Requests that the FDA determine and declare that Tolmetin Capsules 200 mg is suitable for submission in an Abbreviated New Drug Application (ANDA)
›
Response Letter
Response Letter
Nonrulemaking
Other
FDA-2026-P-1820-0008
Pharmaceutical Policy
🔔 Subscribe
Document
Details
The document's own metadata, straight from regulations.gov.
Posted
Jun 5, 2026
Agency
Food and Drug Administration (FDA)
